Cutler Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $223K | Hold |
1,100
| – | – | 0.07% | 261 |
|
|
2023
Q4 | $4K | Sell |
1,100
-200
| -15% | -$117K | ﹤0.01% | 2845 |
|
|
2023
Q3 | $32K | Sell |
1,300
-10,600
| -89% | -$5.46M | ﹤0.01% | 1734 |
|
|
2023
Q2 | $2.8M | Buy |
11,900
+1,900
| +19% | +$797K | 0.39% | 45 |
|
|
2023
Q1 | $1.54M | Sell |
10,000
-1,100
| -10% | -$371K | 0.16% | 132 |
|
|
2022
Q4 | $1.83M | Sell |
11,100
-300
| -3% | -$106K | 0.16% | 140 |
|
|
2022
Q3 | $217K | Buy |
11,400
+600
| +6% | +$190K | 0.01% | 917 |
|
|
2022
Q2 | $311K | Sell |
10,800
-29,900
| -73% | -$8.98M | 0.02% | 746 |
|
|
2022
Q1 | $529K | Buy |
40,700
+28,100
| +223% | +$7.23M | 0.03% | 659 |
|
|
2021
Q4 | $143K | Buy |
12,600
+9,600
| +320% | +$2.43M | 0.01% | 1585 |
|
|
2021
Q3 | $14K | Hold |
3,000
| – | – | ﹤0.01% | 3656 |
|
|
2021
Q2 | $21K | Buy |
+3,000
| New | +$603K | ﹤0.01% | 3268 |
|
|
2020
Q2 | – | Sell |
-1,000
| Closed | -$7K | – | 4656 |
|
|
2020
Q1 | $7K | Buy |
+1,000
| New | +$137K | ﹤0.01% | 2913 |
|
|
2019
Q3 | – | Sell |
-2,500
| Closed | -$1K | – | 4416 |
|
|
2019
Q2 | $1K | Sell |
2,500
-37,000
| -94% | -$4.36M | ﹤0.01% | 3890 |
|
|
2019
Q1 | $204K | Buy |
39,500
+29,100
| +280% | +$3.54M | 0.02% | 639 |
|
|
2018
Q4 | $144K | Sell |
10,400
-2,000
| -16% | -$223K | 0.01% | 817 |
|
|
2018
Q3 | $92K | Buy |
12,400
+3,000
| +32% | +$300K | 0.01% | 1246 |
|
|
2018
Q2 | $8K | Sell |
9,400
-500
| -5% | -$41.1K | ﹤0.01% | 2818 |
|
|
2018
Q1 | $9K | Sell |
9,900
-19,400
| -66% | -$1.56M | ﹤0.01% | 2863 |
|
|
2017
Q4 | $136K | Sell |
29,300
-400
| -1% | -$34K | 0.01% | 1197 |
|
|
2017
Q3 | $210K | Sell |
29,700
-400
| -1% | -$32.8K | 0.01% | 1140 |
|
|
2017
Q2 | $173K | Buy |
30,100
+13,200
| +78% | +$1.08M | 0.01% | 1400 |
|
|
2017
Q1 | $98K | Sell |
16,900
-40,500
| -71% | -$3.24M | ﹤0.01% | 1758 |
|
|
2016
Q4 | $73K | Buy |
57,400
+30,700
| +115% | +$2.29M | ﹤0.01% | 2196 |
|
|
2016
Q3 | $44K | Buy |
26,700
+15,000
| +128% | +$1.2M | ﹤0.01% | 2584 |
|
|
2016
Q2 | $49K | Buy |
11,700
+9,800
| +516% | +$738K | ﹤0.01% | 2370 |
|
|
2016
Q1 | $6K | Sell |
1,900
-500
| -21% | -$37.8K | ﹤0.01% | 4652 |
|
|
2015
Q4 | $5K | Buy |
+2,400
| New | +$199K | ﹤0.01% | 4899 |
|
Other funds holding LLY
Cutler Group's LLY Position: Q1 2024 in Review
Cutler Group sold out of Eli Lilly (LLY) in Q1 2024, closing a stake of 809 shares — an estimated $576K sold.
Cutler Group first reported a position in LLY in Q4 2015 and held it in 18 quarters. The position peaked at $9.94M in Q4 2016. 3,460 funds tracked by Wall St. Rank hold LLY as of Q1 2024.
- Cutler Group reported no remaining Eli Lilly position as of Q1 2024 after selling out during the quarter.
- Cutler Group sold 809 Eli Lilly shares in Q1 2024, an estimated $576K.
- Cutler Group first reported a position in Eli Lilly in Q4 2015 and held it in 18 quarters.
- Cutler Group's Eli Lilly position peaked at $9.94M in Q4 2016.
- 3,460 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.
Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.